15-60497599-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_134261.3(RORA):c.1428C>A(p.Thr476Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.989 in 1,612,332 control chromosomes in the GnomAD database, including 790,256 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.95 ( 69132 hom., cov: 31)
Exomes 𝑓: 0.99 ( 721124 hom. )
Consequence
RORA
NM_134261.3 synonymous
NM_134261.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0770
Genes affected
RORA (HGNC:10258): (RAR related orphan receptor A) The protein encoded by this gene is a member of the NR1 subfamily of nuclear hormone receptors. It can bind as a monomer or as a homodimer to hormone response elements upstream of several genes to enhance the expression of those genes. The encoded protein has been shown to interact with NM23-2, a nucleoside diphosphate kinase involved in organogenesis and differentiation, as well as with NM23-1, the product of a tumor metastasis suppressor candidate gene. Also, it has been shown to aid in the transcriptional regulation of some genes involved in circadian rhythm. Four transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Feb 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 15-60497599-G-T is Benign according to our data. Variant chr15-60497599-G-T is described in ClinVar as [Benign]. Clinvar id is 1327966.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.077 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.992 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.950 AC: 144597AN: 152150Hom.: 69084 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
144597
AN:
152150
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.985 AC: 246683AN: 250322 AF XY: 0.988 show subpopulations
GnomAD2 exomes
AF:
AC:
246683
AN:
250322
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.994 AC: 1450619AN: 1460064Hom.: 721124 Cov.: 39 AF XY: 0.994 AC XY: 722014AN XY: 726500 show subpopulations
GnomAD4 exome
AF:
AC:
1450619
AN:
1460064
Hom.:
Cov.:
39
AF XY:
AC XY:
722014
AN XY:
726500
Gnomad4 AFR exome
AF:
AC:
27611
AN:
33410
Gnomad4 AMR exome
AF:
AC:
44335
AN:
44722
Gnomad4 ASJ exome
AF:
AC:
26116
AN:
26116
Gnomad4 EAS exome
AF:
AC:
39691
AN:
39692
Gnomad4 SAS exome
AF:
AC:
85001
AN:
86210
Gnomad4 FIN exome
AF:
AC:
53414
AN:
53416
Gnomad4 NFE exome
AF:
AC:
1109165
AN:
1110378
Gnomad4 Remaining exome
AF:
AC:
59582
AN:
60352
Heterozygous variant carriers
0
396
792
1189
1585
1981
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
21614
43228
64842
86456
108070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.950 AC: 144704AN: 152268Hom.: 69132 Cov.: 31 AF XY: 0.953 AC XY: 70926AN XY: 74448 show subpopulations
GnomAD4 genome
AF:
AC:
144704
AN:
152268
Hom.:
Cov.:
31
AF XY:
AC XY:
70926
AN XY:
74448
Gnomad4 AFR
AF:
AC:
0.831198
AN:
0.831198
Gnomad4 AMR
AF:
AC:
0.980058
AN:
0.980058
Gnomad4 ASJ
AF:
AC:
1
AN:
1
Gnomad4 EAS
AF:
AC:
1
AN:
1
Gnomad4 SAS
AF:
AC:
0.983637
AN:
0.983637
Gnomad4 FIN
AF:
AC:
0.999906
AN:
0.999906
Gnomad4 NFE
AF:
AC:
0.998486
AN:
0.998486
Gnomad4 OTH
AF:
AC:
0.967833
AN:
0.967833
Heterozygous variant carriers
0
314
629
943
1258
1572
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
910
1820
2730
3640
4550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3442
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Intellectual developmental disorder with or without epilepsy or cerebellar ataxia Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=99/1
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at